The global medical image management market is projected to grow at a rate of 7-8% by 2027. This growth is primarily driven by the increasing volume of imaging procedures, rapid advancements in ...

Encouraging anti-tumour activity seen across all dose levels and in various tumour indications Clinical benefit rate of 80% for 10 patients with HER2+ oesophageal cancer who had received prior therapy ...

LQT-23 is a potent, highly differentiated, first-in-class allosteric small molecule inhibitor of MSH3/MutSβ Unique mechanism of action with potential to slow or stop the progression of HD Cambridge, ...

CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the works council consultation process regarding the wind-down of cell therapy activities has been completed and its Board of Directors ...

AP31969 is a novel, first-in-class, oral SK ion channel inhibitor intended for rhythm control of atrial fibrillation and has recently completed Phase 1 in healthy volunteersPhase 2 trial will assess ...

Global Life Science Consulting Services Market OverviewThe global life science consulting services market is projected to ...

FutureWise Research, a leading global market intelligence firm specialising in healthcare and medical devices, today ...

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2025 financial results after the market close on Monday, February 9, 2026. The ...

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced its participation at the 44th Annual J.P. Morgan ...

Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on ...

LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...

MESA, ARIZONA / ACCESS Newswire / January 5, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced today that the Company has successfully completed its internal readiness testing phase for ...